Kate Jerome serves as the Executive Director and Head of Commercial Operations for Oncology at Replimune, where she plays a pivotal role in shaping the future of skin cancer treatment. With her extensive experience in hospital sales and strategic planning, Kate is at the forefront...
Kate Jerome serves as the Executive Director and Head of Commercial Operations for Oncology at Replimune, where she plays a pivotal role in shaping the future of skin cancer treatment. With her extensive experience in hospital sales and strategic planning, Kate is at the forefront of developing and executing a robust go-to-market strategy that integrates cross-functional teams to drive the commercialization of innovative therapies. Her leadership is characterized by a deep passion for patients and a commitment to progressive science, ensuring that every initiative aligns with the overarching goal of improving patient outcomes.
In her current role, Kate is responsible for P&L ownership and the establishment of a high-performing team dedicated to the successful launch of Replimune’s skin cancer franchise. She collaborates closely with executive leadership to devise comprehensive commercialization strategies that encompass market access, sales effectiveness, and contract negotiation. Her expertise in dermatology and rheumatology enhances her ability to navigate the complexities of the oncology landscape, allowing her to leverage insights that inform effective market positioning and stakeholder engagement.
Kate’s approach to team leadership is rooted in her passion for coaching and development, fostering an environment where innovation thrives and team members are empowered to excel. By prioritizing collaboration and strategic alignment, she ensures that all functional teams work cohesively towards shared objectives. As she continues to drive Replimune’s mission forward, Kate remains committed to advancing the field of oncology through the integration of cutting-edge science and a patient-centric focus.
